Vivoryon Therapeutics N.V. (AMS:VVY)
0.9100
+0.1300 (16.67%)
Nov 4, 2026, 5:35 PM CET
Vivoryon Therapeutics Employees
Vivoryon Therapeutics had 13 employees as of December 31, 2025. The number of employees decreased by 1 or 7.14% compared to the previous year. That makes Vivoryon Therapeutics the 39,427th largest employer in the world and 92nd in the Netherlands.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
€520,615
Market Cap
26.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | -1 | -7.14% |
| Dec 31, 2024 | 14 | -1 | -6.67% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 0 | 0.67% |
| Dec 31, 2021 | 15 | -3 | -17.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ctac N.V. | 329 |
| Ebusco Holding | 248 |
| Almunda Professionals | 183 |
| Alumexx | 71 |
| B.V. Delftsch Aardewerkfabriek "De Porceleyne Fles Anno 1653" | 59 |
| Green Earth Group | 41 |
| Ease2pay | 13 |
| New Amsterdam Invest | 4 |
Vivoryon Therapeutics News
- 3 months ago - Vivoryon Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Vivoryon Therapeutics Quarterly report: Q2 2026 - Filings
- 3 months ago - Vivoryon Therapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Vivoryon Therapeutics Slides: Q2 2026 - Filings
- 3 months ago - Vivoryon Therapeutics Slides: Corporate presentation - Filings
- 4 months ago - Vivoryon Therapeutics Quarterly report: Q1 2026 - Filings
- 6 months ago - Vivoryon Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Vivoryon Therapeutics Annual report: Q4 2025 - Filings